Log in to save to my catalogue

Advanced renal cell carcinoma: pathology and systemic therapy with a new role of zoledronic acid in...

Advanced renal cell carcinoma: pathology and systemic therapy with a new role of zoledronic acid in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1237636192

Advanced renal cell carcinoma: pathology and systemic therapy with a new role of zoledronic acid in management of skeletal metastases

About this item

Full title

Advanced renal cell carcinoma: pathology and systemic therapy with a new role of zoledronic acid in management of skeletal metastases

Author / Creator

Publisher

Poznan: Termedia Publishing House

Journal title

Contemporary oncology (Poznań, Poland), 2005-01, Vol.9 (3), p.143

Language

Formats

Publication information

Publisher

Poznan: Termedia Publishing House

More information

Scope and Contents

Contents

Renal cell carcinoma (RCC) continues to represent a major therapeutic challenge. There is still observed the increased rate of incidence of RCC at the level of 2% per annum. Unfortunately, approximately 30% of patients develop distant metastases at first presentation. Progression of RCC accounts for additional 20% of cases with distant metastases t...

Alternative Titles

Full title

Advanced renal cell carcinoma: pathology and systemic therapy with a new role of zoledronic acid in management of skeletal metastases

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1237636192

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1237636192

Other Identifiers

ISSN

1428-2526

E-ISSN

1897-4309

How to access this item